Senestech (NASDAQ:SNES) Stock Price Crosses Below 50-Day Moving Average – Time to Sell?

Shares of Senestech, Inc. (NASDAQ:SNESGet Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.38 and traded as low as $1.05. Senestech shares last traded at $1.08, with a volume of 34,856 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Senestech currently has a consensus rating of “Sell”.

View Our Latest Stock Report on Senestech

Senestech Stock Performance

The firm has a 50 day moving average of $1.38 and a two-hundred day moving average of $1.64. The stock has a market cap of $5.86 million, a PE ratio of -0.79 and a beta of 0.28. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.78 and a quick ratio of 5.81.

Senestech (NASDAQ:SNESGet Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.02. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%.The firm had revenue of $0.77 million during the quarter, compared to the consensus estimate of $0.60 million. Research analysts predict that Senestech, Inc. will post -1.28 EPS for the current fiscal year.

Insider Activity

In related news, major shareholder Glenbrook Capital Management bought 35,000 shares of the company’s stock in a transaction that occurred on Monday, July 20th. The shares were purchased at an average cost of $1.47 per share, with a total value of $51,450.00. Following the transaction, the insider directly owned 1,057,824 shares of the company’s stock, valued at approximately $1,555,001.28. This represents a 3.42% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last ninety days, insiders have acquired 131,143 shares of company stock valued at $195,491. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Senestech

Several large investors have recently bought and sold shares of the stock. Sabby Management LLC lifted its holdings in shares of Senestech by 195.4% in the 4th quarter. Sabby Management LLC now owns 210,564 shares of the company’s stock valued at $451,000 after purchasing an additional 139,281 shares during the last quarter. DRW Securities LLC boosted its position in shares of Senestech by 171.1% in the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after purchasing an additional 51,818 shares during the period. Renaissance Technologies LLC grew its stake in Senestech by 35.2% during the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after buying an additional 37,165 shares during the last quarter. Jane Street Group LLC purchased a new position in Senestech during the 2nd quarter worth approximately $161,000. Finally, Millennium Management LLC acquired a new position in Senestech during the third quarter worth approximately $126,000. Institutional investors and hedge funds own 5.19% of the company’s stock.

About Senestech

(Get Free Report)

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.

Further Reading

Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.